Moderna, Inc. (MRNA) financial statements (2021 and earlier)

Company profile

Business Address 200 TECHNOLOGY SQUARE
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

Current Assets
Cash, cash equivalents, and short-term investments1,1031,521
Cash and cash equivalents236658
Short-term investments867863
Restricted cash and investments11
Prepaid expense810
Other undisclosed current assets410
Total current assets:1,1291,563
Noncurrent Assets
Finance lease, right-of-use asset10
Operating lease, right-of-use asset86
Property, plant and equipment 212
Long-term investments and receivables160173
Long-term investments160173
Restricted cash and investments1112
Other noncurrent assets23
Other undisclosed noncurrent assets192 
Total noncurrent assets:461399
TOTAL ASSETS:1,5891,962
Current Liabilities
Accounts payable and accrued liabilities75110
Accounts payable731
Accrued liabilities6879
Deferred revenue63
Other liabilities53
Other undisclosed current liabilities 109
Total current liabilities:143223
Noncurrent Liabilities
Long-term debt and lease obligation132 
Finance lease, liability39
Operating lease, liability94
Liabilities, other than long-term debt13910
Deferred revenue139
Deferred rent credit 10
Other liabilities00
Other undisclosed noncurrent liabilities 199
Total noncurrent liabilities:271209
Total liabilities:415432
Stockholders' equity
Stockholders' equity attributable to parent1,1751,530
Common stock00
Additional paid in capital2,6692,538
Accumulated other comprehensive income (loss)2(1)
Accumulated deficit(1,496)(1,007)
Total stockholders' equity:1,1751,530

Income statement (P&L) ($ in millions)

Gross profit:60135
Operating expenses(606)(548)
Operating loss:(546)(413)
Nonoperating income3129
Investment income, nonoperating3927
Other nonoperating income (expense)(8)2
Interest and debt expense(7) 
Other undisclosed income from continuing operations before equity method investments, income taxes7 
Loss from continuing operations before income taxes:(515)(384)
Income tax expense (benefit)1(0)
Net loss attributable to parent:(514)(385)
Preferred stock dividends and other adjustments (17)
Net loss available to common stockholders, diluted:(514)(402)

Comprehensive Income ($ in millions)

Net loss:(514)(385)
Comprehensive loss:(514)(385)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3(0)
Comprehensive loss, net of tax, attributable to parent:(511)(385)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: